Research library

1,783 reports · By date added

Soochow Securities: Liuzhou Pharmaceutical Group: DTP pharmacies drive retail growth, while OTC conversion and an equity investment in a new drug open up room for growth

Quyu Jianpi Tea has entered the public consultation stage for OTC conversion, and existing out-of-hospital channels could help expand its sales. SIF001, a drug in which the company holds an indirect stake, has entered Phase II clinical trials in the United States, but its long-term sales potential still depends on research and development progress.

Ingenic: Rising memory prices lift gross margin, while capacity constraints limit shipment growth next year

Management expects memory gross margin to continue rising in the fourth quarter, but global DRAM capacity is tight, and memory shipments next year are expected to be similar to this year’s. NOR Flash customers are seeking long-term agreements, and newly reserved capacity is expected to come online gradually from the second half of next year.

A-share midday report: Stocks open lower and climb as tech recovers; robotics awaits returning capital

Indices climbed after a lower open, with PCB stocks leading the tech recovery and capital returning to robotics after divergent trading. Cailian Press is watching whether short-term sentiment can improve and how revenue is progressing at robotics supply-chain companies.

Yifeng Pharmacy resumes expansion after store closures, with profit growth outpacing revenue in the first three quarters

In the first three quarters of 2026, Yifeng Pharmacy’s revenue rose 5.49% year on year, while net profit attributable to shareholders rose 10.36%. Guojin Securities believes industry store closures and improving same-store growth at the company could support further growth.

Bernstein: Piotech’s third-quarter revenue misses expectations; doubled orders and improved margins support the outlook

Third-quarter revenue in 2026 rose just 1.8% year on year, but gross margin and recurring net margin increased quarter on quarter. Bernstein sees quarterly fluctuations in revenue recognition, lowered its full-year revenue forecast and maintained its Outperform rating.

Bernstein: New first-line combinations for lung cancer: ADCs show efficacy, bispecific antibodies target longer-term replacement

A Bernstein expert interview suggests that Trop2 ADCs combined with immunotherapy could change first-line treatment for some patients with non-small cell lung cancer, but overall survival benefits, toxicity management and global trials will determine the scope of their use.

Bernstein: Tsingtao Brewery's third-quarter sales volume decline widens as costs and expenses squeeze profits

A decline in low-end products lifted net revenue per hectolitre, but failed to offset higher unit costs and expenses. Bernstein expects aluminium price pressure to persist through 2027 and slightly raised its H-share target price.

Bernstein: UMC bets 8.2 billion dollars on AI capacity expansion, while near-term price increases and gross margin fall short of expectations

UMC’s third-quarter results and fourth-quarter guidance both missed expectations. The company expects average selling prices to rise 10% in 2027 and plans to have AI-related capacity in place by 2030. Bernstein is concerned that depreciation and material costs will limit gross margin improvement.

Bernstein: NAURA Technology Group: Component shortages delay third-quarter revenue; can order growth translate into deliveries?

Third-quarter revenue was about 17% below market consensus, and gross margin also fell due to the customer mix. Bernstein values the growth in orders and improving supply of domestically produced components, but its model also shows rising working-capital and capital-expenditure pressures over the next two years.

Bernstein: Advantest raises full-year guidance: CPUs become a new pillar of test demand, but second-half margins will come under pressure

SoC test equipment drove quarterly revenue above market consensus, prompting the company to accelerate capacity expansion and raise its full-year targets; meanwhile, the depletion of lower-cost inventory and rising component prices will weigh on second-half operating margins.

Goldman Sachs: Commercialization of Chinese Large Language Models Accelerates: Z.AI and MiniMax Revenue Targets, Cost Pressures and Computing Constraints

Experts surveyed by Goldman Sachs expect the performance gap between Chinese and US models to narrow by mid-2027; Z.AI and MiniMax are increasing annualized revenue through enterprise coding demand and new products, respectively, but R&D spending and price competition continue to affect profitability.

J.P. Morgan: Alphabet search growth drops sharply, while cloud revenue doubles but cannot offset near-term profit pressure

Third-quarter search revenue growth slowed to 12%, below the 13%–14% previously discussed by investors. Cloud revenue grew 103% year over year, but AI investment and inventory purchases will continue to weigh on free cash flow. JPMorgan maintained its Overweight rating and lowered its price target.

Goldman Sachs: MARUWA raises AI revenue outlook as expansion and new-plant costs weigh on second-half margin guidance

Products for 1.6T applications drove a 60% quarter-on-quarter increase in AI application revenue, prompting the company to raise its full-year communications business guidance. Meanwhile, depreciation at new plants and lower sales in some businesses put second-half operating margin guidance below the second-quarter level.

Citi: CH Robinson beats earnings expectations, but shares fall 11%: Can efficiency gains offset cost and liability risks?

Third-quarter adjusted earnings per share beat expectations, and lean management and AI improved efficiency, but North American transportation gross margin came under pressure, while the insurance renewal and RXO acquisition also worried investors. Citi maintained its Buy rating and slightly lowered its price target.

J.P. Morgan: Japanese MLCC exports grow above seasonal norms: Taiwan demand stands out as automotive market remains weak

Japan's MLCC export value rose 17% month on month in September 2026, well above historical seasonal levels. JPMorgan sees IT- and AI-related demand as the main driver and expects Japanese manufacturers' quarterly sales to grow.

J.P. Morgan: KLA beats expectations on results and guidance as longer equipment lead times reflect stronger process inspection demand

KLA expects revenue to rise about 14% sequentially next fiscal quarter, while management has raised its 2027 wafer fab equipment spending outlook. JPMorgan is optimistic about inspection demand from advanced processes and packaging, but delivery capacity and gross margins remain constrained.

Goldman Sachs: Samsung Electronics: Memory Drives Profits to New Highs, Buyback Plan Deferred Until Next Year

Third-quarter operating profit was in line with preliminary guidance; Goldman Sachs raised its fourth-quarter profit forecast, citing optimism about AI server memory demand, while awaiting details of Samsung’s shareholder returns.

Goldman Sachs: Sanhua’s third-quarter revenue rises as net profit falls: Can growing liquid-cooling sales support the next phase of growth?

Core third-quarter operations were broadly in line with Goldman Sachs’ expectations, but foreign-exchange and investment fair-value losses weighed on net profit. Liquid-cooling revenue continued to grow, and new secondary-side products could increase the value of content per system; the robotics business remains at different stages of development across its products.

Goldman Sachs: Renesas beats Goldman Sachs’ third-quarter profit forecast. Why is its fourth-quarter margin falling?

Data center and industrial businesses supported the third-quarter margin, but changes in the product mix and cost factors will weigh on the fourth-quarter margin. Goldman Sachs sees the pressure as non-structural and expects sales and margins to improve again from the first quarter of 2027.

Goldman Sachs: US third-quarter growth beats expectations; Goldman Sachs expects cooling consumption to slow the fourth quarter

US real GDP grew at an annualized quarter-on-quarter rate of 3.4% in the third quarter, with strong consumption and investment in AI-related equipment; Goldman Sachs expects consumption to slow as fiscal stimulus fades, bringing fourth-quarter growth down to 1.8%.